All In Biotech

Drug Trial Radar · NCT04879420

Replication of the VERO Osteoporosis Trial in Healthcare Claims Data

Last checked: Nov 19, 2026Latest source record: Jul 27, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

12,757

Actual

Start

Oct 29, 2020

Primary completion

Jun 11, 2021

Study completion Jun 11, 2021

Sponsor

Lead sponsor
Brigham and Women's HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 10, 2021

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
Female only, from 45 years, up to 120 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.

Conditions

  • Osteoporosis

Interventions

  • TeriparatideDrug

    Teriparatide dispensing claim is used as the reference group.

  • RisedronateDrug

    Risedronate dispensing claim is used as the exposure group.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. New vertebral fracturesTime frame: Through study completion (earliest of 730 days or censoring)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Brigham and Women's Hospital

    Boston, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.